The future of European innovation faces significant challenges, particularly regarding the participation of Israeli startups within the Horizon Europe program. This EU initiative, which allocates approximately 95 billion Euros from 2021 to 2027, is designed to unite leading researchers, universities, and technology firms across Europe for groundbreaking projects. However, recent political tensions have sparked discussions around excluding Israeli entities from aspects of this innovation framework.
Political Tensions and the Horizon Europe Program
In July 2025, the European Commission proposed barring Israeli startups from participating in the European Innovation Council (EIC) Accelerator. This move aimed at restricting access to funding and support for companies involved in disruptive technologies like AI and cybersecurity. While Israeli universities and researchers were initially allowed to continue participating in other Horizon projects, this exclusion marked a troubling precedent in how the EU conducts its innovation policies. To date, the proposal has not garnered sufficient support, with major states like Germany and Italy advocating for a more careful examination, while several Central and Eastern European nations outright opposed it.
Conversely, countries such as France and Spain felt the proposal didn’t adequately address the situation in Gaza, calling for escalated measures against Israeli participation in EU funding opportunities. Though officially put on hold, the proposal continues to resurface with ongoing geopolitical tensions. This situation demands immediate attention as Europe begins discussions on its next research framework for 2028 to 2034, creating increased urgency surrounding the role of third-country collaborations, particularly with Israel.
The Impact of Exclusion on European Innovation
Excluding Israel from Horizon Europe could significantly undermine the program’s core objectives. Israeli entities are not merely recipients of European funds; they contribute expertise, innovations, and resources vital for complex research initiatives. Between 2021 and 2024, Israeli institutions gained over a billion euros in funding from Horizon Europe while simultaneously contributing roughly 1.7 billion euros. This dynamic partnership bolsters Europe’s innovation landscape, making Israel a net contributor to the EU’s research ecosystem.
If Israel were to be excluded, international collaborations would face immediate and detrimental effects. European research institutions would lose critical expertise and access to Israel’s dynamic startup ecosystem, which thrives on innovation and technical advancement. Projects might need to be restructured or canceled, ultimately costing European entities financially and hindering their research agendas. The repercussions would be felt most acutely in major cities like Hamburg, Paris, and Barcelona, where collaborations with Israeli startups have proven essential.
A Call to Action for European Policymakers
The collaboration between European and Israeli teams leads to breakthroughs in fields such as personalized medicine, advanced agriculture, and robotics. Institutions like the Technion and the Weizmann Institute generate patents and real-world applications that translate scientific research into marketable innovations—an area where Europe often struggles. Excluding Israel would not address Europe’s existing challenges but would exacerbate them, limiting its capabilities in critical sectors like biotechnology and quantum technology.
As European policymakers prepare for FP10, they must prioritize securing Israel’s involvement in Horizon Europe rather than using its participation as a political bargaining tool during times of conflict. Governments in Dublin, Paris, and Madrid must realize the broader scientific and economic consequences of exclusion. FP10 should remain committed to excellence in research, free from the influence of shifting political ideologies.
In conclusion, Israel’s unrestricted access to the European research landscape from 2028 to 2034 is not only vital for its own future but also essential for the continued success of Europe’s innovation framework. Investing in collaborative efforts with Israel will ultimately benefit Europe’s broader objectives in research and technology.